Oncolytic adenovirus gene therapy - MultivirAlternative Names: Ad-VirRx 007; Ad-VirRx 007 -MultiVir; Ad5-VirRx 007
Latest Information Update: 18 Apr 2016
At a glance
- Originator MultiVir
- Class Antineoplastics; Gene therapies; Oncolytic viruses
- Mechanism of Action Apoptosis regulatory protein stimulants; Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Solid tumours
Most Recent Events
- 18 Apr 2016 Phase-I clinical trials in Solid tumours in USA (Parenteral)